SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-07-001963
Filing Date
2007-03-08
Accepted
2007-03-07 21:56:41
Documents
6
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 ATHEROGENICS, INC. g05890e10vk.htm 10-K 608254
2 EX-23.01 CONSENT OF ERNST & YOUNG LLP g05890exv23w01.htm EX-23.01 2318
3 EX-24.01 POWERS OF ATTORNEY g05890exv24w01.htm EX-24.01 7721
4 EX-31.1 SECTION 302 CERTIFICATION OF CEO g05890exv31w1.htm EX-31.1 6141
5 EX-31.2 SECTION 302 CERTIFICATION OF CFO g05890exv31w2.htm EX-31.2 6177
6 EX-32 SECTION 906 CERTIFICATIONS OF THE CEO AND CFO g05890exv32.htm EX-32 5703
  Complete submission text file 0000950144-07-001963.txt   637595
Mailing Address
Business Address 8995 WESTSIDE PARKWAY ALPHARETTA GA 30004 6783362500
ATHEROGENICS INC (Filer) CIK: 0001107601 (see all company filings)

IRS No.: 582108232 | State of Incorp.: GA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31261 | Film No.: 07679219
SIC: 2834 Pharmaceutical Preparations